Click on image to view larger version.

Figure 1 Serum levels of myeloid-related protein (MRP)-8/MRP-14 in patients with acute Kawasaki disease comparing patients who responded to intravenous immune globulin (IVIG) treatment (left panel) with those who did not (right panel). Blood samples were collected at the time of diagnosis before the initiation of IVIG treatment (5.7 ± 1.5 days). Arrows indicate IVIG treatment. *p < 0.01 versus healthy control patients. p < 0.01 versus before IVIG in each patient group.